These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36497427)

  • 1. Development and External Validation of an Improved Version of the Diagnostic Model for Opportunistic Screening of Malignant Esophageal Lesions.
    Liu Z; Zheng H; Liu M; He Y; Chen Y; Ji P; Fang Z; Xiao P; Li F; Guo C; Yin W; Pan Y; He Z; Ke Y
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical model predicting the risk of esophageal high-grade lesions in opportunistic screening: a multicenter real-world study in China.
    Liu Z; Guo C; He Y; Chen Y; Ji P; Fang Z; Li F; Tang Y; Chen X; Xiao P; Wang C; Yin W; Guo H; Liu M; Pan Y; Liu F; Liu Y; He Z; Ke Y
    Gastrointest Endosc; 2020 Jun; 91(6):1253-1260.e3. PubMed ID: 31911077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and external validation of a quantitative diagnostic model for malignant gastric lesions in clinical opportunistic screening: A multicenter real-world study.
    Zheng H; Liu Z; Chen Y; Ji P; Fang Z; He Y; Guo C; Xiao P; Wang C; Yin W; Li F; Chen X; Liu M; Pan Y; Liu F; Liu Y; He Z; Ke Y
    Chin Med J (Engl); 2024 Feb; ():. PubMed ID: 38403900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Model To Identify Individuals at High Risk for Esophageal Squamous Cell Carcinoma and Precancerous Lesions in Regions of High Prevalence in China.
    Liu M; Liu Z; Cai H; Guo C; Li X; Zhang C; Wang H; Hang D; Liu F; Deng Q; Yang X; Yuan W; Pan Y; Li J; Zhang C; Shen N; He Z; Ke Y
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1538-1546.e7. PubMed ID: 28342951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update and validation of a diagnostic model to identify prevalent malignant lesions in esophagus in general population.
    Liu M; Zhou R; Liu Z; Guo C; Xu R; Zhou F; Liu A; Yang H; Li F; Duan L; Shen L; Wu Q; Zheng H; Tian H; Liu F; Liu Y; Pan Y; Chen H; Hu Z; Cai H; He Z; Ke Y
    EClinicalMedicine; 2022 May; 47():101394. PubMed ID: 35480078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of high-risk individuals for esophageal cancer screening: A prediction model of esophageal squamous cell carcinoma based on a multicenter screening cohort in rural China.
    Chen W; Li H; Ren J; Zheng R; Shi J; Li J; Cao M; Sun D; He S; Sun X; Cao X; Feng S; Zhou J; Luo P; Zha Z; Jia S; Wang J; Ma H; Zeng H; Canfell K; He J
    Int J Cancer; 2021 Jan; 148(2):329-339. PubMed ID: 32663318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a questionnaire-based risk scoring system to identify individuals at high risk for gastric cancer in Chinese populations.
    Zhou R; Zheng H; Liu M; Liu Z; Guo C; Tian H; Liu F; Liu Y; Pan Y; Chen H; Hu Z; Cai H; He Z; Ke Y
    Chin J Cancer Res; 2021 Dec; 33(6):649-658. PubMed ID: 35125809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
    Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
    Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of Iodine Staining Associates With Progression of Esophageal Lesions in a Prospective Endoscopic Surveillance Study in China.
    Liu M; Liu Z; Liu F; Guo C; Xu R; Li F; Liu A; Yang H; Zhang S; Shen L; Duan L; Wu Q; Cao C; Pan Y; Liu Y; Li J; Cai H; He Z; Ke Y
    Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1626-1635.e7. PubMed ID: 31518715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of an Esophageal Squamous Cell Carcinoma Detection Model by Large-Scale MicroRNA Profiling.
    Sudo K; Kato K; Matsuzaki J; Boku N; Abe S; Saito Y; Daiko H; Takizawa S; Aoki Y; Sakamoto H; Niida S; Takeshita F; Fukuda T; Ochiya T
    JAMA Netw Open; 2019 May; 2(5):e194573. PubMed ID: 31125107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral microbiome and risk of malignant esophageal lesions in a high-risk area of China: A nested case-control study.
    Liu F; Liu M; Liu Y; Guo C; Zhou Y; Li F; Xu R; Liu Z; Deng Q; Li X; Zhang C; Pan Y; Ning T; Dong X; Hu Z; Bao H; Cai H; Silva IDS; He Z; Ke Y
    Chin J Cancer Res; 2020 Dec; 32(6):742-754. PubMed ID: 33446997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting malignant transformation of esophageal squamous cell lesions by combined biomarkers in an endoscopic screening program.
    Zhang H; Li H; Ma Q; Yang FY; Diao TY
    World J Gastroenterol; 2016 Oct; 22(39):8770-8778. PubMed ID: 27818592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of a Risk Prediction Model for Esophageal Squamous Cell Carcinoma Using Cohort Studies.
    Wang QL; Ness-Jensen E; Santoni G; Xie SH; Lagergren J
    Am J Gastroenterol; 2021 Apr; 116(4):683-691. PubMed ID: 33982937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and Accuracy of Artificial Intelligence-Assisted Sponge Cytology for Community-Based Esophageal Squamous Cell Carcinoma Screening in China.
    Gao Y; Xin L; Feng YD; Yao B; Lin H; Sun C; An W; Li ZS; Shi RH; Wang LW
    Am J Gastroenterol; 2021 Nov; 116(11):2207-2215. PubMed ID: 34546186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Distribution of esophageal squamous cell cancer and precursor lesions in high-risk areas, Linzhou in Henan province and Feicheng in Shandong province of China, 2005-2009].
    Wang M; Hao C; Zhao D; Li B; Wang J; Lei F; Zhou R; Ma S; Ma Q; Li Y; Feng H; Li X; Wei W
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Aug; 49(8):677-82. PubMed ID: 26733024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A New Online Dynamic Nomogram: Construction and Validation of an Assistant Decision-Making Model for Laryngeal Squamous Cell Carcinoma.
    Liu Y; Han Y; Chen B; Zhang J; Yin S; Li D; Wu Y; Jiang Y; Wang X; Wang J; Fu Z; Shen H; Ding Z; Yao K; Tao Y; Wu J; Liu Y
    Front Oncol; 2022; 12():829761. PubMed ID: 35719922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Intratumoral and Peritumoral Computed Tomography Radiomics for Predicting Pathological Complete Response to Neoadjuvant Chemoradiation in Patients With Esophageal Squamous Cell Carcinoma.
    Hu Y; Xie C; Yang H; Ho JWK; Wen J; Han L; Chiu KWH; Fu J; Vardhanabhuti V
    JAMA Netw Open; 2020 Sep; 3(9):e2015927. PubMed ID: 32910196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bi-parametric magnetic resonance imaging based radiomics for the identification of benign and malignant prostate lesions: cross-vendor validation.
    Ji X; Zhang J; Shi W; He D; Bao J; Wei X; Huang Y; Liu Y; Chen JC; Gao X; Tang Y; Xia W
    Phys Eng Sci Med; 2021 Sep; 44(3):745-754. PubMed ID: 34075559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential diagnosis for esophageal protruded lesions using a deep convolution neural network in endoscopic images.
    Zhang M; Zhu C; Wang Y; Kong Z; Hua Y; Zhang W; Si X; Ye B; Xu X; Li L; Heng D; Liu B; Tian S; Wu J; Dang Y; Zhang G
    Gastrointest Endosc; 2021 Jun; 93(6):1261-1272.e2. PubMed ID: 33065026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using a deep learning system in endoscopy for screening of early esophageal squamous cell carcinoma (with video).
    Cai SL; Li B; Tan WM; Niu XJ; Yu HH; Yao LQ; Zhou PH; Yan B; Zhong YS
    Gastrointest Endosc; 2019 Nov; 90(5):745-753.e2. PubMed ID: 31302091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.